Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vascular Surgery

Free Subscription Articles published in J Am Coll Cardiol Retrieve available abstracts of 203 articles: HTML format

Single Articles

April 2024
1. SIBBING D
   Modulation of Antiplatelet Therapy in PCI-Treated Patients: A Rocky Road Toward More Individualized Treatment.
   J Am Coll Cardiol. 2024;83:1382-1385.
   PubMed    
   
   
   
2. THOMAS CD, Franchi F, Rossi JS, Keeley EC, et al
   Effectiveness of Clopidogrel vs Alternative P2Y(12) Inhibitors Based on the ABCD-GENE Score.
   J Am Coll Cardiol. 2024;83:1370-1381.
   PubMed     Abstract available
   
   
   
3. SCHNEIDER PA, Olin JW
   Paclitaxel-Mortality Risk Hypothesis Debunked: What We Learned and How It Will Change Future Clinical Trials.
   J Am Coll Cardiol. 2024;83:1222-1224.
   PubMed    
   
   
   
4. WARGNY M, Leux C, Chatellier G, Coudol S, et al
   Mortality in a Nationwide Practice-Based Cohort Receiving Paclitaxel-Coated Devices for Lower Limb Peripheral Artery Disease.
   J Am Coll Cardiol. 2024;83:1207-1221.
   PubMed     Abstract available
   
   
   March 2024
5. ZIERATH R, Shah AM
   Reply: Aging in Patients With Fontan Circulation: Raison d'etre of Right Ventricle.
   J Am Coll Cardiol. 2024;83:e119.
   PubMed    
   
   
   
6. MURAKAMI T
   Aging in Patients With Fontan Circulation: Raison d'etre of Right Ventricle.
   J Am Coll Cardiol. 2024;83:e117.
   PubMed    
   
   
   
7. BATCHELOR WB, Damluji AA
   Rehospitalization After PCI vs CABG for Left Main Disease: Refocusing Our Lens.
   J Am Coll Cardiol. 2024;83:1082-1084.
   PubMed    
   
   
   
8. KOSMIDOU I, Shahim B, Dressler O, Redfors B, et al
   Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease.
   J Am Coll Cardiol. 2024;83:1073-1081.
   PubMed     Abstract available
   
   
   
9. BRIGUORI C, Quintavalle C, Mariano E, D'Agostino A, et al
   Kidney Injury After Minimal Radiographic Contrast Administration in Patients With Acute Coronary Syndromes.
   J Am Coll Cardiol. 2024;83:1059-1069.
   PubMed     Abstract available
   
   
   
10. SCHWANN TA, Engelman DT
    Anemia and Sex Disparity in CABG Mortality: In Search of a Grand Unified Theory.
    J Am Coll Cardiol. 2024;83:929-931.
    PubMed    
    
    
    
11. HARIK L, Habib RH, Dimagli A, Rahouma M, et al
    Intraoperative Anemia Mediates Sex Disparity in Operative Mortality After Coronary Artery Bypass Grafting.
    J Am Coll Cardiol. 2024;83:918-928.
    PubMed     Abstract available
    
    
    
12. MUKHERJEE D
    Is There a Role for Routine Stress Testing After Multivessel or Left Main PCI?
    J Am Coll Cardiol. 2024;83:901-903.
    PubMed    
    
    
    
13. LEE JM, Kim H, Park YS, Jo HH, et al
    Surveillance Stress Testing After Percutaneous Intervention for Patients With Multivessel or Left Main Coronary Disease.
    J Am Coll Cardiol. 2024;83:890-900.
    PubMed     Abstract available
    
    
    February 2024
14. KIM YY, Hoteit MA
    Turning to "Omics" in Understanding Fontan-Associated Liver Disease.
    J Am Coll Cardiol. 2024;83:739-740.
    PubMed    
    
    
    
15. BRAVO-JAIMES K, Wu X, Reardon LC, Lluri G, et al
    Intrahepatic Transcriptomics Differentiate Advanced Fibrosis and Clinical Outcomes in Adults With Fontan Circulation.
    J Am Coll Cardiol. 2024;83:726-738.
    PubMed     Abstract available
    
    
    
16. DIMAIO JM, McCullough KA, Widmer RJ
    A Post Hoc Analysis of ISCHEMIA: Are All Events Created Equal?
    J Am Coll Cardiol. 2024;83:559-561.
    PubMed    
    
    
    January 2024
17. STONE GW, Ali ZA, Hochman JS, Maron DJ, et al
    REPLY: Interpreting the Impact of Complete Revascularization in the ISCHEMIA Trial.
    J Am Coll Cardiol. 2024;83:e39-e40.
    PubMed    
    
    
    
18. GUYTON RA, Halkos ME
    Benefit of Complete Anatomic Revascularization in ISCHEMIA: Reprise of a Familiar Theme.
    J Am Coll Cardiol. 2024;83:e37.
    PubMed    
    
    
    
19. DIMITRIADIS K, Pyrpyris N, Tsioufis K
    Functional vs Anatomical Complete Revascularization: Is There an "ISCHEMIA" of FFR?
    J Am Coll Cardiol. 2024;83:e35.
    PubMed    
    
    
    
20. HIRUMA T, Kitamura M, Takamisawa I, Izumi Y, et al
    Predictors of Repeated Septal Reduction After Alcohol Septal Ablation in Patients With Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2024;83:546-548.
    PubMed    
    
    
    
21. CAPODANNO D, Spagnolo M
    Optical Coherence Tomography or Intravascular Ultrasound for Complex PCI: Different Approaches, Similar Outcomes.
    J Am Coll Cardiol. 2024;83:414-416.
    PubMed    
    
    
    
22. BATES ER
    Clinically Significant Differences Between P2Y(12) Inhibitor Monotherapy and Aspirin Monotherapy Have Yet to Be Demonstrated.
    J Am Coll Cardiol. 2024;83:e9-e10.
    PubMed    
    
    
    
23. TEHRANI BN, Batchelor WB, Spinosa D
    High-Risk Acute Pulmonary Embolism: Where Do We Go From Here?
    J Am Coll Cardiol. 2024;83:44-46.
    PubMed    
    
    
    
24. BELLEMAIN-APPAIX A, Montalescot G
    Clopidogrel for Long-Term Secondary Prevention After Coronary Artery Stenting.
    J Am Coll Cardiol. 2024;83:32-34.
    PubMed    
    
    
    December 2023
25. GRINES CL, DuPont A
    Lesion Selection and Optimizing PCI: Intravascular Hemodynamics, Imaging, or Both?
    J Am Coll Cardiol. 2023;82:2177-2178.
    PubMed    
    
    
    
26. KUNO T, Kiyohara Y, Maehara A, Ueyama HA, et al
    Comparison of Intravascular Imaging, Functional, or Angiographically Guided Coronary Intervention.
    J Am Coll Cardiol. 2023;82:2167-2176.
    PubMed     Abstract available
    
    
    November 2023
27. PAI RG
    Potential Mechanisms of Troponin Release in Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2023;82:e215.
    PubMed    
    
    
    
28. KURLANSKY PA, Bittl JA
    Learning From Machines to Predict Mortality After Surgical or Percutaneous Revascularization.
    J Am Coll Cardiol. 2023;82:2125-2127.
    PubMed    
    
    
    
29. NINOMIYA K, Kageyama S, Shiomi H, Kotoku N, et al
    Can Machine Learning Aid the Selection of Percutaneous vs Surgical Revascularization?
    J Am Coll Cardiol. 2023;82:2113-2124.
    PubMed     Abstract available
    
    
    
30. WERESKI R, Chapman AR, Mills NL
    Reply: Potential Mechanisms of Troponin Release in Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2023;82:e217.
    PubMed    
    
    
    
31. BARRABES JA, Rodenas-Alesina E, Mila L
    Delineating the Benefits of an Invasive Strategy in Octogenarians With Non-ST-Segment Elevation Acute Coronary Syndromes.
    J Am Coll Cardiol. 2023;82:2031-2033.
    PubMed    
    
    
    
32. REDFORS B, Stone GW, Alexander JH, Bates ER, et al
    Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial.
    J Am Coll Cardiol. 2023 Nov 8:S0735-1097(23)07988.
    PubMed     Abstract available
    
    
    October 2023
33. WATANABE H, Morimoto T, Natsuaki M, Yamamoto K, et al
    Clopidogrel versus Aspirin Monotherapy Beyond 1 Year After PCI: STOPDAPT-2 5-Year Results.
    J Am Coll Cardiol. 2023 Oct 18:S0735-1097(23)07750.
    PubMed     Abstract available
    
    
    
34. YANG S, Kang J, Park KW, Hur SH, et al
    Comparison of Antiplatelet Monotherapies After Percutaneous Coronary Intervention According to Clinical, Ischemic, and Bleeding Risks.
    J Am Coll Cardiol. 2023;82:1565-1578.
    PubMed     Abstract available
    
    
    
35. ORTEGA-PAZ L, Sabate M, Angiolillo DJ
    Long-Term Clopidogrel Monotherapy After Percutaneous Coronary Intervention: Will the Pupil Surpass the Master?
    J Am Coll Cardiol. 2023;82:1579-1582.
    PubMed    
    
    
    
36. KANG DY, Ahn JM, Yun SC, Hur SH, et al
    Guiding Intervention for Complex Coronary Lesions by Optical Coherence Tomography or Intravascular Ultrasound.
    J Am Coll Cardiol. 2023 Oct 17:S0735-1097(23)07816.
    PubMed     Abstract available
    
    
    
37. ARGO MB, Barron DJ, Eghtesady P, Yerebakan C, et al
    Outcomes After Hybrid Palliation for Infants With Critical Left Heart Obstruction.
    J Am Coll Cardiol. 2023;82:1427-1441.
    PubMed     Abstract available
    
    
    September 2023
38. POLZL L, Engler C, Sterzinger P, Lohmann R, et al
    Association of High-Sensitivity Cardiac Troponin T With 30-Day and 5-Year Mortality After Cardiac Surgery.
    J Am Coll Cardiol. 2023;82:1301-1312.
    PubMed     Abstract available
    
    
    
39. STONE GW, Ali ZA, O'Brien SM, Rhodes G, et al
    Impact of Complete Revascularization in the ISCHEMIA Trial.
    J Am Coll Cardiol. 2023;82:1175-1188.
    PubMed     Abstract available
    
    
    
40. THRANE PG, Olesen KKW, Thim T, Gyldenkerne C, et al
    Mortality Trends After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2023;82:999-1010.
    PubMed     Abstract available
    
    
    August 2023
41. NAYAK A, Hall SA, Uriel N, Goldstein DJ, et al
    Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device.
    J Am Coll Cardiol. 2023;82:771-781.
    PubMed     Abstract available
    
    
    
42. MENDIETA G, Mehta S, Baber U, Angiolillo DJ, et al
    Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions.
    J Am Coll Cardiol. 2023;82:687-700.
    PubMed     Abstract available
    
    
    
43. FANG J, Liu Y, Zhu Y, Li R, et al
    First-in-Human Transapical Beating-Heart Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy.
    J Am Coll Cardiol. 2023;82:575-586.
    PubMed     Abstract available
    
    
    
44. LEE SJ, Joo JH, Park S, Kim C, et al
    Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2023;82:401-410.
    PubMed     Abstract available
    
    
    July 2023
45. AHMAD Y, Velazquez EJ
    The Interplay of Complete Revascularization and Angina: More Is More?
    J Am Coll Cardiol. 2023;82:314-316.
    PubMed    
    
    
    
46. CAO L, Zhang H, Ge Y, Guo W, et al
    Avoiding Stroke in Patients Undergoing Endovascular Aortic Arch Repair: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:265-277.
    PubMed     Abstract available
    
    
    
47. GRAGNANO F, Cao D, Pirondini L, Franzone A, et al
    P2Y(12) Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events.
    J Am Coll Cardiol. 2023;82:89-105.
    PubMed     Abstract available
    
    
    
48. KUMBHANI DJ, de Lemos JA
    The Optimal Antiplatelet Agent for Secondary Prevention of Coronary Artery Disease: Ring Out the Old?
    J Am Coll Cardiol. 2023;82:106-108.
    PubMed    
    
    
    June 2023
49. GARTENBERG AJ, Krishnamurthy G, Srinivasan A, Escobar FA, et al
    Intrahepatic and Periduodenal Embolization for Protein-Losing Enteropathy Patients With Congenital Heart Disease.
    J Am Coll Cardiol. 2023;81:2476-2478.
    PubMed    
    
    
    
50. ABDULKARIM A, Shaji S, Elfituri M, Gunsaulus M, et al
    Pulmonary Complications in Patients With Fontan Circulation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:2434-2444.
    PubMed     Abstract available
    
    
    
51. DAUERMAN HL
    Primary PCI, Thrombus, and COVID-19: Remembrance of Things Past.
    J Am Coll Cardiol. 2023;81:2417-2419.
    PubMed    
    
    
    
52. RATHOD KS, Teoh Z, Tyrlis A, Choudry FA, et al
    Thrombus Burden and Outcomes in Patients With COVID-19 Presenting With STEMI Across the Pandemic.
    J Am Coll Cardiol. 2023;81:2406-2416.
    PubMed     Abstract available
    
    
    
53. SIMARD T, Sarma D, Miranda WR, Jain CC, et al
    Pathogenesis, Evaluation, and Management of Pulmonary Vein Stenosis: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:2361-2373.
    PubMed     Abstract available
    
    
    
54. GRAGNANO F, Mehran R, Calabro P, Valgimigli M, et al
    Reply: DAPT Shortening After Complex PCI: Examining the Fine Print.
    J Am Coll Cardiol. 2023;81:e193.
    PubMed    
    
    
    
55. APOSTOLOS A, Vasilagkos G, Toutouzas K, Tsigkas G, et al
    DAPT Shortening After Complex PCI: Examining the Fine Print.
    J Am Coll Cardiol. 2023;81:e191.
    PubMed    
    
    
    
56. STOUT K, Buber J
    The Last Stage of the Fontan Operation?
    J Am Coll Cardiol. 2023;81:2172-2174.
    PubMed    
    
    
    
57. LEWIS MJ, Reardon LC, Aboulhosn J, Haeffele C, et al
    Morbidity and Mortality in Adult Fontan Patients After Heart or Combined Heart-Liver Transplantation.
    J Am Coll Cardiol. 2023;81:2161-2171.
    PubMed     Abstract available
    
    
    
58. LEWIS MJ, Reardon LC, Aboulhosn J, Haeffele C, et al
    Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation.
    J Am Coll Cardiol. 2023;81:2149-2160.
    PubMed     Abstract available
    
    
    May 2023
59. STONE GW, Gaudino M
    Reconsidering the Direction of Coronary Revascularization Trials.
    J Am Coll Cardiol. 2023;81:1974-1978.
    PubMed    
    
    
    
60. KANJI R, Gue YX, Memtsas V, Spencer NH, et al
    Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2023;81:1918-1932.
    PubMed     Abstract available
    
    
    
61. STONE GW, Kereiakes DJ, Gori T, Metzger DC, et al
    Five-Year Clinical Outcomes After Coronary Bioresorbable Scaffolds and Drug-Eluting Stents: The ABSORB IV Randomized Trial.
    J Am Coll Cardiol. 2023 May 13:S0735-1097(23)05527.
    PubMed     Abstract available
    
    
    April 2023
62. HAGER A
    Invasive Cardiopulmonary Exercise Testing in Patients With Fontan Circulation.
    J Am Coll Cardiol. 2023;81:1601-1604.
    PubMed    
    
    
    March 2023
63. TRUESDELL AG, Mehta A, Cilia LA
    Myocardial Infarction, Cardiogenic Shock, and Cardiac Arrest: Management Made Simple, But Not Too Simple.
    J Am Coll Cardiol. 2023;81:1177-1180.
    PubMed    
    
    
    
64. ZEYMER U, Alushi B, Noc M, Mamas MA, et al
    Influence of Culprit Lesion Intervention on Outcomes in Infarct-Related Cardiogenic Shock With Cardiac Arrest.
    J Am Coll Cardiol. 2023;81:1165-1176.
    PubMed     Abstract available
    
    
    February 2023
65. TU S, Xu B, Chen L, Hong H, et al
    Short-Term Risk Stratification of Non-Flow-Limiting Coronary Stenosis by Angiographically Derived Radial Wall Strain.
    J Am Coll Cardiol. 2023;81:756-767.
    PubMed     Abstract available
    
    
    
66. FLATHER M, Talukder S
    Saphenous Vein Grafts for Coronary Surgery: More May Be Less.
    J Am Coll Cardiol. 2023;81:726-728.
    PubMed    
    
    
    
67. SHIH E, Squiers JJ, Banwait JK, Mack MJ, et al
    Vein Graft Use and Long-Term Survival Following Coronary Bypass Grafting.
    J Am Coll Cardiol. 2023;81:713-725.
    PubMed     Abstract available
    
    
    
68. TRUESDELL AG, Alasnag MA, Kaul P, Rab ST, et al
    Intravascular Imaging During Percutaneous Coronary Intervention: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;81:590-605.
    PubMed     Abstract available
    
    
    
69. BHATT DL
    Optimal Antiplatelet Therapy Revisited: When Is a Single Better Than a Double?
    J Am Coll Cardiol. 2023;81:553-556.
    PubMed    
    
    
    
70. GRAGNANO F, Mehran R, Branca M, Franzone A, et al
    P2Y(12) Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions.
    J Am Coll Cardiol. 2023;81:537-552.
    PubMed     Abstract available
    
    
    
71. KERN KB
    Timely Reperfusion for Everyone...Except for Some Out-of-Hospital Cardiac Arrest Patients?
    J Am Coll Cardiol. 2023;81:457-459.
    PubMed    
    
    
    
72. SPIRITO A, Vaisnora L, Papadis A, Iacovelli F, et al
    Acute Coronary Occlusion in Patients With Non-ST-Segment Elevation Out-of-Hospital Cardiac Arrest.
    J Am Coll Cardiol. 2023;81:446-456.
    PubMed     Abstract available
    
    
    January 2023
73. LIN J, Lluri G
    Thromboprophylaxis in the Fontan Circulation: Long-Awaited Validation.
    J Am Coll Cardiol. 2023;81:390-393.
    PubMed    
    
    
    
74. VAN DEN EYNDE J, Possner M, Alahdab F, Veldtman G, et al
    Thromboprophylaxis in Patients With Fontan Circulation.
    J Am Coll Cardiol. 2023;81:374-389.
    PubMed     Abstract available
    
    
    
75. BONACA MP, Hogan SE
    Tradeoffs in Approach to PAD Revascularization: Shared Decision Making in the Spotlight.
    J Am Coll Cardiol. 2023;81:371-373.
    PubMed    
    
    
    
76. FARHAN S, Enzmann FK, Bjorkman P, Kamran H, et al
    Revascularization Strategies for Patients With Femoropopliteal Peripheral Artery Disease.
    J Am Coll Cardiol. 2023;81:358-370.
    PubMed     Abstract available
    
    
    
77. FELDMAN DN, Klein AJP
    Drug-Coated Balloons in Peripheral Vascular Interventions: Leave No Trace and Walk Away?
    J Am Coll Cardiol. 2023;81:250-252.
    PubMed    
    
    
    
78. SHISHEHBOR MH, Scheinert D, Jain A, Brodmann M, et al
    Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients With Femoropopliteal Arterial Disease.
    J Am Coll Cardiol. 2023;81:237-249.
    PubMed     Abstract available
    
    
    
79. DHAUN N, Pugh D, Youngstein T
    Percutaneous Intervention in Takayasu Arteritis: Potential Advantages of Procedural Perseverance.
    J Am Coll Cardiol. 2023;81:65-67.
    PubMed    
    
    
    
80. JOSEPH G, Thomson VS, Attumalil TV, Mathen PG, et al
    Outcomes of Percutaneous Intervention in Patients With Takayasu Arteritis.
    J Am Coll Cardiol. 2023;81:49-64.
    PubMed     Abstract available
    
    
    November 2022
81. SONG L, Xu B, Tu S, Guan C, et al
    2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary Interventions.
    J Am Coll Cardiol. 2022;80:2089-2101.
    PubMed     Abstract available
    
    
    
82. DAVIDSON LJ, Cleveland JC, Welt FG, Anwaruddin S, et al
    A Practical Approach to Left Main Coronary Artery Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:2119-2134.
    PubMed     Abstract available
    
    
    
83. ROYSE A, Ren J, Royse C, Tian DH, et al
    Coronary Artery Bypass Surgery Without Saphenous Vein Grafting: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;80:1833-1843.
    PubMed     Abstract available
    
    
    
84. TARDIF JC, Thorin E
    Inhibition of the Mechanistic Target of Rapamycin in Acute Myocardial Infarction.
    J Am Coll Cardiol. 2022;80:1815-1817.
    PubMed    
    
    
    
85. NICHOL G, West A
    Contemporary Approaches to Reducing Morbidity and Mortality in Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2022;80:1799-1801.
    PubMed    
    
    
    
86. GONG W, Yan Y, Wang X, Zheng W, et al
    Risk Factors for In-Hospital Cardiac Arrest in Patients With ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2022;80:1788-1798.
    PubMed     Abstract available
    
    
    
87. KORJIAN S, Yeh RW, Cutlip DE
    Ischemic Risk Prediction Scores: Practice-Changing or Just Practice?
    J Am Coll Cardiol. 2022;80:1748-1750.
    PubMed    
    
    
    
88. BATRA G, Lindback J, Becker RC, Harrington RA, et al
    Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2022;80:1735-1747.
    PubMed     Abstract available
    
    
    October 2022
89. BOHME M, Desch S, Rosolowski M, Scholz M, et al
    Impact of Clonal Hematopoiesis in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction.
    J Am Coll Cardiol. 2022;80:1545-1556.
    PubMed     Abstract available
    
    
    September 2022
90. JIN Z, Xu B, Yang X, Jia R, et al
    Coronary Intervention Guided by Quantitative Flow Ratio vs Angiography in Patients With or Without Diabetes.
    J Am Coll Cardiol. 2022;80:1254-1264.
    PubMed     Abstract available
    
    
    
91. SATTAR Y, Aronow HD, Alam M
    Drug-Coated Balloon Failure Following Femoro-Popliteal Intervention: Where to Draw the Line?
    J Am Coll Cardiol. 2022;80:1251-1253.
    PubMed    
    
    
    
92. KRISHNAN P, Farhan S, Schneider P, Kamran H, et al
    Determinants of Drug-Coated Balloon Failure in Patients Undergoing Femoropopliteal Arterial Intervention.
    J Am Coll Cardiol. 2022;80:1241-1250.
    PubMed     Abstract available
    
    
    
93. KINLAY S
    Post-PCI Antithrombotic Treatment With High Bleeding Risk.
    J Am Coll Cardiol. 2022;80:1238-1240.
    PubMed    
    
    
    
94. SMITS PC, Frigoli E, Vranckx P, Ozaki Y, et al
    Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk.
    J Am Coll Cardiol. 2022;80:1220-1237.
    PubMed     Abstract available
    
    
    August 2022
95. FAGUNDES A JR, Morrow DA, Oyama K, Furtado RHM, et al
    Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER Trial.
    J Am Coll Cardiol. 2022;80:887-897.
    PubMed     Abstract available
    
    
    
96. STAHLI BE, Klingenberg R, Heg D, Branca M, et al
    Randomized Trial of Early mTOR Inhibition in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2022 Aug 24. pii: S0735-1097(22)06613.
    PubMed     Abstract available
    
    
    
97. OUZOUNIAN M, Tadros RO, Svensson LG, Lyden SP, et al
    Thoracoabdominal Aortic Disease and Repair: JACC Focus Seminar, Part 3.
    J Am Coll Cardiol. 2022;80:845-856.
    PubMed     Abstract available
    
    
    
98. HENSLEY SE, Upchurch GR Jr
    Repair of Abdominal Aortic Aneurysms: JACC Focus Seminar, Part 1.
    J Am Coll Cardiol. 2022;80:821-831.
    PubMed     Abstract available
    
    
    
99. VALGIMIGLI M, Frigoli E, Vranckx P, Ozaki Y, et al
    Impact of Medication Nonadherence in a Clinical Trial of Dual Antiplatelet Therapy.
    J Am Coll Cardiol. 2022;80:766-778.
    PubMed     Abstract available
    
    
    July 2022
100. GIUSTINO G, Colombo A, Camaj A, Yasumura K, et al
     Coronary In-Stent Restenosis: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;80:348-372.
     PubMed     Abstract available
     
     
     June 2022
101. EVANGELISTA A, Pineda V, Guala A, Bijnens B, et al
     False Lumen Flow Assessment by Magnetic Resonance Imaging and Long-Term Outcomes in Uncomplicated Aortic Dissection.
     J Am Coll Cardiol. 2022;79:2415-2427.
     PubMed     Abstract available
     
     
     
102. VERDOIA M, Gioscia R, Rognoni A
     Updates on the Management of STEMI in 2021: Beyond COVID-19.
     J Am Coll Cardiol. 2022;79:2245-2246.
     PubMed    
     
     
     
103. GARCIA S, Dehghani P, Stanberry L, Grines C, et al
     Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19.
     J Am Coll Cardiol. 2022;79:2236-2244.
     PubMed     Abstract available
     
     
     May 2022
104. RAJKUMAR CA, Wereski R, Parsonage W, Cullen L, et al
     Association Between High-Sensitivity Cardiac Troponin, Myocardial Ischemia, and Revascularization in Stable Coronary Artery Disease.
     J Am Coll Cardiol. 2022;79:2185-2187.
     PubMed    
     
     
     
105. DORFMAN AL, Del Nido PJ
     The Right Ventricle and Tricuspid Valve in Fontan Failure: A Role for Early Surgical Management.
     J Am Coll Cardiol. 2022;79:1846-1848.
     PubMed    
     
     
     
106. KING G, Buratto E, Celermajer DS, Grigg L, et al
     Natural and Modified History of Atrioventricular Valve Regurgitation in Patients With Fontan Circulation.
     J Am Coll Cardiol. 2022;79:1832-1845.
     PubMed     Abstract available
     
     
     
107. SHERRID MV, Massera D, Swistel DG
     Surgical Septal Myectomy and Alcohol Ablation: Not Equivalent in Efficacy or Survival.
     J Am Coll Cardiol. 2022;79:1656-1659.
     PubMed    
     
     
     
108. CUI H, Schaff HV, Wang S, Lahr BD, et al
     Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2022;79:1647-1655.
     PubMed     Abstract available
     
     
     April 2022
109. OLIN JW, Johnston-Cox H
     Angioplasty to Treat Pulmonary Hypertension in Takayasu Arteritis: An Uncommon Treatment for an Uncommon Disease.
     J Am Coll Cardiol. 2022;79:1489-1491.
     PubMed    
     
     
     
110. ZHOU YP, Wei YP, Yang YJ, Xu XQ, et al
     Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension.
     J Am Coll Cardiol. 2022;79:1477-1488.
     PubMed     Abstract available
     
     
     
111. GRANGER CB, Krychtiuk KA, Gersh BJ
     Personalizing Choice of CABG vs PCI for Multivessel Disease: Predictive Model Falls Short.
     J Am Coll Cardiol. 2022;79:1474-1476.
     PubMed    
     
     
     
112. TAKAHASHI K, Serruys PW, Fuster V, Farkouh ME, et al
     External Validation of the FREEDOM Score for Individualized Decision Making Between CABG and PCI.
     J Am Coll Cardiol. 2022;79:1458-1473.
     PubMed     Abstract available
     
     
     
113. GAUDINO M, Di Franco A, Cao D, Giustino G, et al
     Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7.
     J Am Coll Cardiol. 2022;79:1407-1425.
     PubMed     Abstract available
     
     
     
114. MEHRAN R, Cao D, Vogel B
     Rethinking the Role of Impaired Renal Function in Multivessel PCI or CABG.
     J Am Coll Cardiol. 2022;79:1285-1287.
     PubMed    
     
     
     
115. KIM TO, Kang DY, Ahn JM, Kim SO, et al
     Prognostic Impact of Mildly Impaired Renal Function in Patients Undergoing Multivessel Coronary Revascularization.
     J Am Coll Cardiol. 2022;79:1270-1284.
     PubMed     Abstract available
     
     
     March 2022
116. KWONG RY, Cardoso R, Jerosch-Herold M
     Quantitative CMR Perfusion in Patients After CABG: Emerging and Promising Evidence.
     J Am Coll Cardiol. 2022;79:1152-1154.
     PubMed    
     
     
     
117. WONG CCY, Yong ASC, Keech A, Ada C, et al
     Evolution of the Coronary Microcirculation After Restoration of Epicardial Blood Flow in STEMI.
     J Am Coll Cardiol. 2022;79:1127-1128.
     PubMed    
     
     
     
118. GOTBERG M, Berntorp K, Rylance R, Christiansen EH, et al
     5-Year Outcomes of PCI Guided by Measurement of Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve.
     J Am Coll Cardiol. 2022;79:965-974.
     PubMed     Abstract available
     
     
     February 2022
119. MCCARTHY CP, Januzzi JL Jr
     Periprocedural MI as an Endpoint in Clinical Trials: A Proposed Path Forward.
     J Am Coll Cardiol. 2022;79:527-529.
     PubMed    
     
     
     
120. UEKI Y, Otsuka T, Bar S, Koskinas KC, et al
     Frequency and Outcomes of Periprocedural MI in Patients With Chronic Coronary Syndromes Undergoing PCI.
     J Am Coll Cardiol. 2022;79:513-526.
     PubMed     Abstract available
     
     
     
121. VRANCKX P, Angiolillo DJ, Valgimigli M
     Patients With Atrial Fibrillation and PCI or ACS: Does Predicted Risk Matter?
     J Am Coll Cardiol. 2022;79:428-431.
     PubMed    
     
     
     
122. HARSKAMP RE, Fanaroff AC, Lopes RD, Wojdyla DM, et al
     Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention.
     J Am Coll Cardiol. 2022;79:417-427.
     PubMed     Abstract available
     
     
     January 2022
123. LOCCOH EC, Joynt Maddox KE, Wang Y, Kazi DS, et al
     Rural-Urban Disparities in Outcomes of Myocardial Infarction, Heart Failure, and Stroke in the United States.
     J Am Coll Cardiol. 2022;79:267-279.
     PubMed     Abstract available
     
     
     
124. HAN Y, Liao Z, Li Y, Zhao X, et al
     Magnetically Controlled Capsule Endoscopy for Assessment of Antiplatelet Therapy-Induced Gastrointestinal Injury.
     J Am Coll Cardiol. 2022;79:116-128.
     PubMed     Abstract available
     
     
     
125. LIU T, Howarth AG, Chen Y, Nair AR, et al
     Intramyocardial Hemorrhage and the "Wave Front" of Reperfusion Injury Compromising Myocardial Salvage.
     J Am Coll Cardiol. 2022;79:35-48.
     PubMed     Abstract available
     
     
     December 2021
126. GRINES CL, Marshall JJ
     Early Discharge After ST-Segment Elevation Myocardial Infarction: The Days Are Getting Shorter!
     J Am Coll Cardiol. 2021;78:2561-2562.
     PubMed    
     
     
     
127. RATHOD KS, Comer K, Casey-Gillman O, Moore L, et al
     Early Hospital Discharge Following PCI for Patients With STEMI.
     J Am Coll Cardiol. 2021;78:2550-2560.
     PubMed     Abstract available
     
     
     November 2021
128. NATHAN AS, Manandhar P, Wojdyla D, Nelson A, et al
     Hospital-Level Percutaneous Coronary Intervention Performance With Simulated Risk Avoidance.
     J Am Coll Cardiol. 2021;78:2213-2217.
     PubMed    
     
     
     
129. GIRI J, Fanaroff AC
     1 Month of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: The New Standard?
     J Am Coll Cardiol. 2021;78:2073-2075.
     PubMed    
     
     
     
130. HARRIS KM, Mena-Hurtado C, Arham A, Burg MM, et al
     Increasing Prevalence of Critical Limb Ischemia Hospitalizations With Distinct Mental Health Burden Among Younger Adults.
     J Am Coll Cardiol. 2021;78:2126-2128.
     PubMed    
     
     
     
131. VALGIMIGLI M, Cao D, Angiolillo DJ, Bangalore S, et al
     Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI.
     J Am Coll Cardiol. 2021;78:2060-2072.
     PubMed     Abstract available
     
     
     
132. PARIKH PB
     Dual Antiplatelet Duration After DES: Is it Time to Say Goodbye to 1-Year DAPT?
     J Am Coll Cardiol. 2021;78:1987-1989.
     PubMed    
     
     
     
133. DAVIDSON BP, Hodovan J, Layoun ME, Golwala H, et al
     Echocardiographic Ischemic Memory Molecular Imaging for Point-of-Care Detection of Myocardial Ischemia.
     J Am Coll Cardiol. 2021;78:1990-2000.
     PubMed     Abstract available
     
     
     
134. RIOUFOL G, Derimay F, Roubille F, Perret T, et al
     Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease.
     J Am Coll Cardiol. 2021;78:1875-1885.
     PubMed     Abstract available
     
     
     
135. ZELLER T, Bohme T
     Antiproliferative Device Coatings: Efficacy Without Adverse Drug Effect?
     J Am Coll Cardiol. 2021;78:1779-1781.
     PubMed    
     
     
     
136. HESS CN, Patel MR, Bauersachs RM, Anand SS, et al
     Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD.
     J Am Coll Cardiol. 2021;78:1768-1778.
     PubMed     Abstract available
     
     
     October 2021
137. METKUS TS, Grant MC, Zwischenberger B, Higgins R, et al
     Reply: When Will We Stop Debating on the Value of TEE in CABG?
     J Am Coll Cardiol. 2021;78:e139-e140.
     PubMed    
     
     
     
138. ZHAN Y, Brovman EY, Cobey F
     When Will We Stop Debating on the Value of TEE in CABG?
     J Am Coll Cardiol. 2021;78:e137.
     PubMed    
     
     
     
139. SULLIVAN AE, Nanna MG, Wang TY, Bhatt DL, et al
     Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;78:1550-1563.
     PubMed     Abstract available
     
     
     
140. AN KR, de Mestral C, Tam DY, Qiu F, et al
     Surveillance Imaging Following Acute Type A Aortic Dissection.
     J Am Coll Cardiol. 2021 Oct 5. pii: S0735-1097(21)06218.
     PubMed     Abstract available
     
     
     September 2021
141. GUO MH, Vo TX, Horsthuis K, Rahmouni K, et al
     Durability of Minimally Invasive Coronary Artery Bypass Grafting.
     J Am Coll Cardiol. 2021;78:1390-1391.
     PubMed    
     
     
     
142. KASTRATI A, Coughlan JJ, Ndrepepa G
     Primary PCI, Late Presenting STEMI, and the Limits of Time.
     J Am Coll Cardiol. 2021;78:1306-1308.
     PubMed    
     
     
     
143. BOUISSET F, Gerbaud E, Bataille V, Coste P, et al
     Percutaneous Myocardial Revascularization in Late-Presenting Patients With STEMI.
     J Am Coll Cardiol. 2021;78:1291-1305.
     PubMed     Abstract available
     
     
     
144. SQUIERS JJ, DiMaio JM
     SYNTAX Score II 2020: A Remake Worth the Price of Admission?
     J Am Coll Cardiol. 2021;78:1239-1241.
     PubMed    
     
     
     
145. HARA H, Shiomi H, van Klaveren D, Kent DM, et al
     External Validation of the SYNTAX Score II 2020.
     J Am Coll Cardiol. 2021;78:1227-1238.
     PubMed     Abstract available
     
     
     August 2021
146. WU EB, Brilakis ES, Mashayekhi K, Tsuchikane E, et al
     Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;78:840-853.
     PubMed     Abstract available
     
     
     
147. HSIA J, Szarek M, Anand S, Patel MR, et al
     Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial.
     J Am Coll Cardiol. 2021;78:757-759.
     PubMed    
     
     
     
148. GRADY RM, Canter MW, Wan F, Shmalts AA, et al
     Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary Hypertension.
     J Am Coll Cardiol. 2021;78:468-477.
     PubMed     Abstract available
     
     
     July 2021
149. SERRUYS PW, Ono M, Garg S, Hara H, et al
     Percutaneous Coronary Revascularization: JACC Historical Breakthroughs in Perspective.
     J Am Coll Cardiol. 2021;78:384-407.
     PubMed     Abstract available
     
     
     
150. BRENER SJ
     Refinements in Predicting In-Hospital Mortality Following PCI: The Science and Art of Competing Risk Analysis.
     J Am Coll Cardiol. 2021;78:230-233.
     PubMed    
     
     
     
151. SONNY A, Joseph L
     Improving CABG Mortality Further: Striving Toward Perfection.
     J Am Coll Cardiol. 2021;78:123-125.
     PubMed    
     
     
     
152. DOENST T, Bonow RO, Bhatt DL, Falk V, et al
     Improving Terminology to Describe Coronary Artery Procedures: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;78:180-188.
     PubMed     Abstract available
     
     
     
153. BODEN WE, Gersh BJ
     Defining the Proper SYNTAX for Long-Term Benefit of Myocardial Revascularization With Optimal Medical Therapy.
     J Am Coll Cardiol. 2021;78:39-41.
     PubMed    
     
     
     
154. KAWASHIMA H, Serruys PW, Ono M, Hara H, et al
     Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization.
     J Am Coll Cardiol. 2021;78:27-38.
     PubMed     Abstract available
     
     
     June 2021
155. ZALEWSKI PD, Tvorogova Z, Abdo A, Wawer AA, et al
     Harvesting Endothelial Cells During Routine Invasive Coronary Procedures.
     J Am Coll Cardiol. 2021;77:3136-3138.
     PubMed    
     
     
     
156. BARTHELEMY O, Rouanet S, Zeymer U, Thiele H, et al
     Reply: The Residual SYNTAX Score: A Useful Tool to Predict Outcomes in Cardiogenic Shock.
     J Am Coll Cardiol. 2021;77:2872-2873.
     PubMed    
     
     
     
157. LI X, Ni S
     Could Residual SYNTAX Score Predict the Prognosis of Patients With Cardiogenic Shock?
     J Am Coll Cardiol. 2021;77:2872.
     PubMed    
     
     
     
158. BURGESS SN, Juergens CP, Mussap CJ, Lo STH, et al
     Cardiogenic Shock, the Residual SYNTAX Score, and Prognosis: Corroborative "Real-World" Data.
     J Am Coll Cardiol. 2021;77:2871-2872.
     PubMed    
     
     
     
159. HESS CN, Fu JW, Gundrum J, Allen LaPointe NM, et al
     Diabetes Mellitus and Risk Stratification After Peripheral Artery Revascularization.
     J Am Coll Cardiol. 2021;77:2867-2869.
     PubMed    
     
     
     
160. HIRA RS
     Revascularizing Complex CAD in Elderly Patients: The Coming-of-Age Story of Percutaneous Coronary Intervention.
     J Am Coll Cardiol. 2021;77:2774-2776.
     PubMed    
     
     
     
161. ONO M, Serruys PW, Hara H, Kawashima H, et al
     10-Year Follow-Up After Revascularization in Elderly Patients With Complex Coronary Artery Disease.
     J Am Coll Cardiol. 2021;77:2761-2773.
     PubMed     Abstract available
     
     
     May 2021
162. FOGEL MA
     The Fontan: "Straining" to Understand That "The Bigger They Come, The Harder They Fall".
     J Am Coll Cardiol. 2021;77:2490-2493.
     PubMed    
     
     
     
163. MEYER SL, St Clair N, Powell AJ, Geva T, et al
     Integrated Clinical and Magnetic Resonance Imaging Assessments Late After Fontan Operation.
     J Am Coll Cardiol. 2021;77:2480-2489.
     PubMed     Abstract available
     
     
     
164. ALVAREZ-FUENTE M, Ayala A, Garrido-Lestache E, Bermudez-Canete R, et al
     Long-Term Complications After Aortic Coarctation Stenting.
     J Am Coll Cardiol. 2021;77:2448-2450.
     PubMed    
     
     
     
165. PARIKH PB, Bhatt DL, Bhasin V, Anker SD, et al
     Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:2432-2447.
     PubMed     Abstract available
     
     
     
166. MARLEVI D, Edelman ER
     Vascular Lesion-Specific Drug Delivery Systems: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:2413-2431.
     PubMed     Abstract available
     
     
     
167. LEITER LA, Bhatt DL, McGuire DK, Teoh H, et al
     Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials.
     J Am Coll Cardiol. 2021;77:2366-2377.
     PubMed     Abstract available
     
     
     
168. BAUERSACHS RM, Szarek M, Brodmann M, Gudz I, et al
     Total Ischemic Event Reduction with Rivaroxaban after Peripheral Arterial Revascularization in the VOYAGER PAD Trial.
     J Am Coll Cardiol. 2021 May 7. pii: S0735-1097(21)05016.
     PubMed     Abstract available
     
     
     
169. VINCIGUERRA M, Spadaccio C, Tennyson C, Karuppannan M, et al
     Management of Patients With Aortocoronary Saphenous Vein Graft Aneurysms: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:2236-2253.
     PubMed     Abstract available
     
     
     
170. FAROUX L, Lhermusier T, Vincent F, Nombela-Franco L, et al
     ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2021;77:2187-2199.
     PubMed     Abstract available
     
     
     April 2021
171. METKUS TS, Thibault D, Grant MC, Badhwar V, et al
     Utilization and outcomes of transesophageal echocardiography in 1.3 million CABG procedures.
     J Am Coll Cardiol. 2021 Apr 28. pii: S0735-1097(21)04930.
     PubMed     Abstract available
     
     
     
172. CASTRO-DOMINGUEZ YS, Wang Y, Minges KE, McNamara RL, et al
     Predicting In-Hospital Mortality in Patients Undergoing Percutaneous Coronary Intervention.
     J Am Coll Cardiol. 2021 Apr 28. pii: S0735-1097(21)04934.
     PubMed     Abstract available
     
     
     
173. GARCIA S, Dehghani P, Grines C, Davidson L, et al
     Initial Findings From the North American COVID-19 Myocardial Infarction Registry.
     J Am Coll Cardiol. 2021;77:1994-2003.
     PubMed     Abstract available
     
     
     
174. YAMMINE H, Briggs CS, Rolle QV, Ballast JK, et al
     Simultaneous Transcatheter Aortic Valve Replacement and Endovascular Aortic Aneurysm Repair.
     J Am Coll Cardiol. 2021;77:2156-2157.
     PubMed    
     
     
     
175. TANG GHL, Tadros RO
     Endovascular Aortic Repair in Nonagenarians: Select Well and Time Appropriately.
     J Am Coll Cardiol. 2021;77:1900-1902.
     PubMed    
     
     
     
176. PRENDES CF, Dayama A, Panneton JM, Stana J, et al
     Endovascular Aortic Repair in Nonagenarian Patients.
     J Am Coll Cardiol. 2021;77:1891-1899.
     PubMed     Abstract available
     
     
     
177. CHO KH, Han X, Ahn JH, Hyun DY, et al
     Long-Term Outcomes of Patients With Late Presentation of ST-Segment Elevation Myocardial Infarction.
     J Am Coll Cardiol. 2021;77:1859-1870.
     PubMed     Abstract available
     
     
     
178. RIDKER PM
     Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates: A Next Step for Atherothrombosis Treatment and Prevention.
     J Am Coll Cardiol. 2021;77:1856-1858.
     PubMed    
     
     
     
179. BROCH K, Anstensrud AK, Woxholt S, Sharma K, et al
     Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.
     J Am Coll Cardiol. 2021;77:1845-1855.
     PubMed     Abstract available
     
     
     
180. PERICAS JM, Llopis J, Jimenez-Exposito MJ, Kourany WM, et al
     Infective Endocarditis in Patients on Chronic Hemodialysis.
     J Am Coll Cardiol. 2021;77:1629-1640.
     PubMed     Abstract available
     
     
     March 2021
181. EGBE AC, Borlaug BA
     Reply: Abnormal Pulmonary Vascular Reserve in Fontan: Pulmonary Vascular Disease Versus Diastolic Dysfunction.
     J Am Coll Cardiol. 2021;77:1596-1597.
     PubMed    
     
     
     
182. CEDARS A, Opotowsky A, Tedford RJ, Burkhoff D, et al
     Resist Neglecting Diastolic Dysfunction in Fontan Physiology.
     J Am Coll Cardiol. 2021;77:1595-1596.
     PubMed    
     
     
     
183. LATUS H, Apitz C
     Exercise-Induced Pulmonary Hypertension: The Final Answer to Characterize Pulmonary Vascular Disease in Fontan Patients?
     J Am Coll Cardiol. 2021;77:1594-1595.
     PubMed    
     
     
     
184. SABA PS, Parodi G, Ganau A
     From Risk Factors to Clinical Disease: New Opportunities and Challenges for Cardiovascular Risk Prediction.
     J Am Coll Cardiol. 2021;77:1436-1438.
     PubMed    
     
     
     
185. VANDERHEYDEN M, Bartunek J, Neskovic AN, Milicic D, et al
     TRVD Therapy in Acute HF: Proof of Concept in Animal Model and Initial Clinical Experience.
     J Am Coll Cardiol. 2021;77:1481-1483.
     PubMed    
     
     
     
186. LLANOS-CHEA F, Jelani QU, Trejo-Paredes C, Curtis JP, et al
     Lack of Guideline-Directed Medical Therapy in Patients Undergoing Endovascular Procedures for Critical Limb Ischemia.
     J Am Coll Cardiol. 2021;77:1374-1375.
     PubMed    
     
     
     
187. NAKASHIMA CAK, Dallan LAO, Lisboa LAF, Jatene FB, et al
     Platelet Reactivity in Patients With Acute Coronary Syndromes Awaiting Surgical Revascularization.
     J Am Coll Cardiol. 2021;77:1277-1286.
     PubMed     Abstract available
     
     
     
188. CUTLIP DE
     Standing the Test of Time: A Device and Patient Perspective.
     J Am Coll Cardiol. 2021;77:1179-1181.
     PubMed    
     
     
     February 2021
189. MCCARTHY CP, Kolte D, Kennedy KF, Vaduganathan M, et al
     Patient Characteristics and Clinical Outcomes of Type 1 Versus Type 2 Myocardial Infarction.
     J Am Coll Cardiol. 2021;77:848-857.
     PubMed     Abstract available
     
     
     
190. KRAWISZ AK, Rosenfield K, White CJ, Jaff MR, et al
     Clinical Impact of Contralateral Carotid Occlusion in Patients Undergoing Carotid Artery Revascularization.
     J Am Coll Cardiol. 2021;77:835-844.
     PubMed     Abstract available
     
     
     
191. MOSES JW, Prasad M
     Are All Total Occlusions Created Equal?: Striving for Complete Revascularization While Differentiating Apples From Oranges.
     J Am Coll Cardiol. 2021;77:541-543.
     PubMed    
     
     
     
192. KAWASHIMA H, Takahashi K, Ono M, Hara H, et al
     Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions.
     J Am Coll Cardiol. 2021;77:529-540.
     PubMed     Abstract available
     
     
     
193. KODALI S, Hahn RT, Eleid MF, Kipperman R, et al
     Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation.
     J Am Coll Cardiol. 2021;77:345-356.
     PubMed     Abstract available
     
     
     January 2021
194. OHMAN EM, Nanna MG
     Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain?
     J Am Coll Cardiol. 2021;77:268-270.
     PubMed    
     
     
     
195. LURZ P, Stephan von Bardeleben R, Weber M, Sitges M, et al
     Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation.
     J Am Coll Cardiol. 2021;77:229-239.
     PubMed     Abstract available
     
     
     
196. KOCHAR A, Varshney AS, Wang DE
     Residual SYNTAX Score After Revascularization in Cardiogenic Shock: When Is Complete Complete?
     J Am Coll Cardiol. 2021;77:156-158.
     PubMed    
     
     
     
197. BARTHELEMY O, Rouanet S, Brugier D, Vignolles N, et al
     Predictive Value of the Residual SYNTAX Score in Patients With Cardiogenic Shock.
     J Am Coll Cardiol. 2021;77:144-155.
     PubMed     Abstract available
     
     
     
198. LAWTON JS
     Why Not Give All Patients the Opportunity to Have the Benefits of BITA Grafting?
     J Am Coll Cardiol. 2021;77:27-28.
     PubMed    
     
     
     
199. GOLDSTEIN BH, Kreutzer J
     Transcatheter Intervention for Congenital Defects Involving the Great Vessels: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;77:80-96.
     PubMed     Abstract available
     
     
     
200. WANG H, Zhang Y, Xin F, Jiang H, et al
     Calcium-Induced Autonomic Denervation in Patients With Post-Operative Atrial Fibrillation.
     J Am Coll Cardiol. 2021;77:57-67.
     PubMed     Abstract available
     
     
     
201. GAUDINO M, Di Franco A, Flather M, Gerry S, et al
     Association of Age With 10-Year Outcomes After Coronary Surgery in the Arterial Revascularization Trial.
     J Am Coll Cardiol. 2021;77:18-26.
     PubMed     Abstract available
     
     
     December 2020
202. RAO SV, Vidovich MI, Gilchrist IC, Gulati R, et al
     2021 ACC Expert Consensus Decision Pathway on Same-Day Discharge After Percutaneous Coronary Intervention: A Report of the American College of Cardiology Solution Set Oversight Committee.
     J Am Coll Cardiol. 2020 Dec 28. pii: S0735-1097(20)37778.
     PubMed    
     
     
     November 2020
203. KUMBHANI DJ, Cannon CP, Beavers CJ, Bhatt DL, et al
     2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report
     J Am Coll Cardiol. 2020 Nov 26. pii: S0735-1097(20)36615.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge.